2-(dimethylamino)ethyl 2-(2-ethylbutoxy)-2,2-diphenylacetate CAS NO.3579-62-2

Denaverine is an antispasmodic drug. It was developed in Germany and patented in 1974. Denaverine hydrochloride is used in veterinary medicine under the trade name Sensiblex as a muscle relaxant for the myometrium of cows and dogs during childbirth. Under the trade name Spasmalgan, it has also been used in humans for the treatment of urogenital and gastrointestinal spasms.